173 related articles for article (PubMed ID: 14976595)
1. Low antibody levels against cell wall-attached proteins of Streptococcus pyogenes predispose for severe invasive disease.
Akesson P; Rasmussen M; Mascini E; von Pawel-Rammingen U; Janulczyk R; Collin M; Olsen A; Mattsson E; Olsson ML; Bjorck L; Christensson B
J Infect Dis; 2004 Mar; 189(5):797-804. PubMed ID: 14976595
[TBL] [Abstract][Full Text] [Related]
2. Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome.
Eriksson BK; Andersson J; Holm SE; Norgren M
J Infect Dis; 1999 Aug; 180(2):410-8. PubMed ID: 10395857
[TBL] [Abstract][Full Text] [Related]
3. Human leukocyte antigen class II haplotypes that protect against or predispose to streptococcal toxic shock.
Llewelyn M
Clin Infect Dis; 2005 Nov; 41 Suppl 7():S445-8. PubMed ID: 16237645
[TBL] [Abstract][Full Text] [Related]
4. IdeS, a highly specific immunoglobulin G (IgG)-cleaving enzyme from Streptococcus pyogenes, is inhibited by specific IgG antibodies generated during infection.
Akesson P; Moritz L; Truedsson M; Christensson B; von Pawel-Rammingen U
Infect Immun; 2006 Jan; 74(1):497-503. PubMed ID: 16369006
[TBL] [Abstract][Full Text] [Related]
5. The flesh-eating bacterium: what's next?
Stevens DL
J Infect Dis; 1999 Mar; 179 Suppl 2():S366-74. PubMed ID: 10081509
[TBL] [Abstract][Full Text] [Related]
6. Contribution of protein G-related alpha2-macroglobulin-binding protein to bacterial virulence in a mouse skin model of group A streptococcal infection.
Toppel AW; Rasmussen M; Rohde M; Medina E; Chhatwal GS
J Infect Dis; 2003 Jun; 187(11):1694-703. PubMed ID: 12751026
[TBL] [Abstract][Full Text] [Related]
7. Invasive group A streptococcal disease.
Stevens DL
Infect Agents Dis; 1996 Jun; 5(3):157-66. PubMed ID: 8805078
[TBL] [Abstract][Full Text] [Related]
8. Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production.
Norrby-Teglund A; Kaul R; Low DE; McGeer A; Newton DW; Andersson J; Andersson U; Kotb M
J Immunol; 1996 Apr; 156(8):3057-64. PubMed ID: 8609429
[TBL] [Abstract][Full Text] [Related]
9. Invasive group A streptococcal disease. Association with a lack of anti-exotoxin antibodies.
Mascini EM; Hazenberg MM; van Dalen A; Verhoef-Verhage LA; van Leeuwen NJ; Verhoef J; van Dijk H
Adv Exp Med Biol; 1997; 418():921-2. PubMed ID: 9331799
[No Abstract] [Full Text] [Related]
10. Nosocomial transmission of invasive group a streptococcus from patient to health care worker.
Lacy MD; Horn K
Clin Infect Dis; 2009 Aug; 49(3):354-7. PubMed ID: 19580415
[TBL] [Abstract][Full Text] [Related]
11. Relatedness of Streptococcus canis from canine streptococcal toxic shock syndrome and necrotizing fasciitis.
DeWinter LM; Prescott JF
Can J Vet Res; 1999 Apr; 63(2):90-5. PubMed ID: 10369564
[TBL] [Abstract][Full Text] [Related]
12. Invasive group A streptococcal disease in the Netherlands: evidence for a protective role of anti-exotoxin A antibodies.
Mascini EM; Jansze M; Schellekens JF; Musser JM; Faber JA; Verhoef-Verhage LA; Schouls L; van Leeuwen WJ; Verhoef J; van Dijk H
J Infect Dis; 2000 Feb; 181(2):631-8. PubMed ID: 10669348
[TBL] [Abstract][Full Text] [Related]
13. Immune-response against Streptococcus pyogenes in the development of abdominal aortic aneurysm--a population-based case-control study.
Wanhainen A; Rasmussen M; Björck L; Björck M
Vasa; 2008 May; 37(2):143-9. PubMed ID: 18622964
[TBL] [Abstract][Full Text] [Related]
14. Systemic cytokine response in moribund mice of streptococcal toxic shock syndrome model.
Saito M; Kajiwara H; Iida K; Hoshina T; Kusuhara K; Hara T; Yoshida S
Microb Pathog; 2011 Feb; 50(2):109-13. PubMed ID: 21146602
[TBL] [Abstract][Full Text] [Related]
15. [Invasive streptococcal infections].
Kosina P; Plísek S; Dostál V; Morávková M; Cermák P; Preis J; Lukes A; Kracmarová R; Krausová J
Klin Mikrobiol Infekc Lek; 2007 Dec; 13(6):220-4. PubMed ID: 18320500
[TBL] [Abstract][Full Text] [Related]
16. [Flesh-eating bacteria infection of an immunocompromised patient].
Slavei K; Hauser B; Pénzes I; Ondrejka P; Faller J
Magy Seb; 2001 Oct; 54(5):334-6. PubMed ID: 11723740
[TBL] [Abstract][Full Text] [Related]
17. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004.
O'Loughlin RE; Roberson A; Cieslak PR; Lynfield R; Gershman K; Craig A; Albanese BA; Farley MM; Barrett NL; Spina NL; Beall B; Harrison LH; Reingold A; Van Beneden C;
Clin Infect Dis; 2007 Oct; 45(7):853-62. PubMed ID: 17806049
[TBL] [Abstract][Full Text] [Related]
18. Variations in emm type among group A streptococcal isolates causing invasive or noninvasive infections in a nationwide study.
Ekelund K; Darenberg J; Norrby-Teglund A; Hoffmann S; Bang D; Skinhøj P; Konradsen HB
J Clin Microbiol; 2005 Jul; 43(7):3101-9. PubMed ID: 16000420
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil-derived hyperresistinemia in severe acute streptococcal infections.
Johansson L; Linnér A; Sundén-Cullberg J; Haggar A; Herwald H; Loré K; Treutiger CJ; Norrby-Teglund A
J Immunol; 2009 Sep; 183(6):4047-54. PubMed ID: 19717514
[TBL] [Abstract][Full Text] [Related]
20. Antibody orientation at bacterial surfaces is related to invasive infection.
Nordenfelt P; Waldemarson S; Linder A; Mörgelin M; Karlsson C; Malmström J; Björck L
J Exp Med; 2012 Dec; 209(13):2367-81. PubMed ID: 23230002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
